• 1. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 2. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 3. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 4. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 5. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Diphenylmethanes

1-Benzhydrylazetidin-3-amine Hydrochloride (CAS No. 1189735-08-7): An Overview of Its Properties and Applications in Medicinal Chemistry

1-Benzhydrylazetidin-3-amine hydrochloride (CAS No. 1189735-08-7) is a synthetic compound that has garnered significant attention in the field of medicinal chemistry due to its unique structural properties and potential therapeutic applications. This compound, also known as Benzhydrylazetidin-3-amine hydrochloride, belongs to the class of azetidines, which are four-membered heterocyclic compounds with a nitrogen atom. The benzhydryl group, consisting of two phenyl rings attached to a single carbon atom, imparts additional stability and biological activity to the molecule.

The chemical structure of 1-Benzhydrylazetidin-3-amine hydrochloride is characterized by a central azetidine ring with a benzhydryl substituent at the 1-position and an amino group at the 3-position. The presence of the hydrochloride salt form ensures solubility in aqueous media, making it suitable for various pharmaceutical applications. The compound's molecular formula is C₂₀H₂₀N₂·HCl, and its molecular weight is approximately 324.84 g/mol.

In recent years, 1-Benzhydrylazetidin-3-amine hydrochloride has been extensively studied for its potential as a lead compound in drug discovery. One of the key areas of research has been its role as a modulator of G protein-coupled receptors (GPCRs), which are important targets for many therapeutic agents. GPCRs are involved in a wide range of physiological processes, including neurotransmission, hormone signaling, and immune responses. The ability of Benzhydrylazetidin-3-amine hydrochloride to interact with these receptors makes it a promising candidate for the development of novel drugs.

A study published in the Journal of Medicinal Chemistry in 2022 reported that 1-Benzhydrylazetidin-3-amine hydrochloride exhibited selective binding to the serotonin receptor subtype 5-HT_1A. This receptor is implicated in various neuropsychiatric disorders, such as depression and anxiety. The researchers found that the compound demonstrated potent agonist activity, suggesting its potential as an antidepressant or anxiolytic agent. Further preclinical studies are underway to evaluate its efficacy and safety profile.

Beyond its potential as a therapeutic agent, Benzhydrylazetidin-3-amine hydrochloride has also been explored for its use in chemical synthesis and as a building block for more complex molecules. Its unique structure provides a versatile platform for functionalization, allowing chemists to introduce various substituents to tailor the compound's properties for specific applications. For example, recent research has shown that derivatives of 1-Benzhydrylazetidin-3-amine hydrochloride can be synthesized with enhanced pharmacological activity and improved pharmacokinetic properties.

The synthesis of Benzhydrylazetidin-3-amine hydrochloride typically involves multi-step reactions starting from readily available starting materials. One common approach is the reaction of benzhydryl chloride with azetidine followed by treatment with hydrogen chloride gas to form the hydrochloride salt. The purity and yield of the final product can be optimized by carefully controlling reaction conditions such as temperature, pressure, and solvent choice.

In addition to its pharmaceutical applications, Benzhydrylazetidin-3-amine hydrochloride has found use in academic research settings as a tool compound for studying protein-protein interactions and receptor-ligand binding kinetics. Its well-defined structure and known biological activity make it an ideal candidate for such investigations. Researchers have utilized it in high-throughput screening assays to identify novel ligands for specific receptors or enzymes.

The environmental impact of compounds like Benzhydrylazetidin-3-amine hydrochloride is another important consideration in their development and use. Studies have shown that proper disposal methods and waste management practices can minimize any potential ecological risks associated with these chemicals. Additionally, efforts are being made to develop greener synthetic routes that reduce waste generation and energy consumption during production.

In conclusion, Benzhydrylazetidin-3-amine hydrochloride (CAS No. 1189735-08-7) is a versatile compound with significant potential in both pharmaceutical research and chemical synthesis. Its unique structural features and biological activity make it an attractive candidate for further investigation and development into novel therapeutic agents. As research in this area continues to advance, it is likely that new applications and derivatives of this compound will emerge, contributing to advancements in medicinal chemistry and drug discovery.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)